Impact of VEGF gene polymorphisms in elderly cancer patients: clinical outcome and toxicity

被引：1
|
作者：
Della-Morte, David [1 ,2 ]
Riondino, Silvia [1 ,2 ]
Ferroni, Patrizia [2 ]
Palmirotta, Raffaele [2 ]
Pastore, Donatella [1 ]
Lauro, Davide [1 ]
Guadagni, Fiorella [2 ]
Roselli, Mario [1 ]
机构：
[1] Univ Roma Tor Vergata, Dept Syst Med, Sch Med, I-00133 Rome, Italy
[2] IRCCS San Raffaele Pisana Res Ctr, Biomarker Discovery & Adv Technol BioDAT Lab, Rome, Italy
来源：
PHARMACOGENOMICS | 2015年 / 16卷 / 01期
关键词：
angiogenesis; cancer; elderly; genetics; single nucleotide polymorphisms; tumor prognosis; vascular endothelial growth factors; VEGF; VEGF inhibitors; ENDOTHELIAL-GROWTH-FACTOR; RENAL-CELL CARCINOMA; METASTATIC COLORECTAL-CANCER; SINGLE NUCLEOTIDE POLYMORPHISMS; GENDER-SPECIFIC ASSOCIATION; BEVACIZUMAB-BASED THERAPY; ADVANCED BREAST-CANCER; LUNG-CANCER; PROSTATE-CANCER; TUMOR ANGIOGENESIS;
D O I：
10.2217/PGS.14.136
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Vascular endothelial growth factors (VEGFs) are the key regulators in angiogenesis and have been shown to play a significant role in the progression and prognosis of angiogenesis-related diseases, such as cancer. VEGF inhibitors are a current pharmacological antitumoral strategy. However, despite the strong association between aging and cancer incidence and progression, recent findings suggest impaired angiogenesis accompanied by a reduced expression of VEGF in cells derived from aging subjects. Specific variations of VEGF genes have been demonstrated to be genetic determinants for susceptibility, outcome and therapy response, especially for the solid tumors. Considering the complications present in frail elderly patients, analysis of VEGF genetic polymorphisms in these subjects may further help in tailoring an antiangiogenic pharmacological strategy, and in improving our ability to better understand prognosis during therapy-related to cancer.
引用
收藏
页码：61 / 78
页数：18
相关论文
共 50 条
  • [31] VEGF gene polymorphisms and susceptibility to colorectal cancer disease in Italian population
    Paolo Maltese
    Emanuele Canestrari
    Annamaria Ruzzo
    Francesco Graziano
    Alfredo Falcone
    Fotios Loupakis
    Giuseppe Tonini
    Daniele Santini
    Mauro Magnani
    International Journal of Colorectal Disease, 2009, 24 : 165 - 170
  • [32] Vascular endothelial growth factor polymorphisms and clinical outcome in patients with metastatic breast cancer treated with weekly docetaxel
    Koutras, A. K.
    Kotoula, V.
    Papadimitriou, C.
    Dionysopoulos, D.
    Zagouri, F.
    Kalofonos, H. P.
    Kourea, H. P.
    Skarlos, D. V.
    Samantas, E.
    Papadopoulou, K.
    Kosmidis, P.
    Pectasides, D.
    Fountzilas, G.
    PHARMACOGENOMICS JOURNAL, 2014, 14 (03) : 248 - 255
  • [33] Relationship between VEGF Gene Polymorphisms and Serum VEGF Protein Levels in Patients with Rheumatoid Arthritis
    Paradowska-Gorycka, Agnieszka
    Pawlik, Andrzej
    Romanowska-Prochnicka, Katarzyna
    Haladyj, Ewa
    Malinowski, Damian
    Stypinska, Barbara
    Manczak, Malgorzata
    Olesinska, Marzena
    PLOS ONE, 2016, 11 (08):
  • [34] The Ability of Polymorphisms in DNA Repair Enzymes to Predict Clinical Outcome in Colorectal Cancer Patients
    Gajjar, Kinjal
    Kobawala, Toral
    Vora, Hemangini
    Ghosh, Nandita
    MIDDLE EAST JOURNAL OF CANCER, 2020, 11 (03) : 260 - 272
  • [35] eNOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: final results of the ePHAS study
    Gardini, Andrea Casadei
    Marisi, Giorgia
    Faloppi, Luca
    Scarpi, Emanuela
    Foschi, Francesco Giuseppe
    Iavarone, Massimo
    Lauletta, Gianfranco
    Corbelli, Jody
    Valgiusti, Martina
    Facchetti, Floriana
    della Corte, Cristina
    Neri, Luca Maria
    Tamberi, Stefano
    Cascinu, Stefano
    Scartozzi, Mario
    Amadori, Dino
    Nanni, Oriana
    Tenti, Elena
    Ulivi, Paola
    Frassineti, Giovanni Luca
    ONCOTARGET, 2016, 7 (19) : 27988 - 27999
  • [36] VEGF and bFGF gene polymorphisms in Polish patients with B-CLL
    Wrobel, Tomasz
    Mazur, Grzegorz
    Dzietczenia, Justyna
    Gebura, Katarzyna
    Kuliczkowski, Kazimierz
    Bogunia-Kubik, Katarzyna
    MEDICAL ONCOLOGY, 2013, 30 (01)
  • [37] Polymorphisms in the 5′- and 3′-untranslated region of the VEGF gene and sporadic breast cancer risk and clinicopathologic characteristics
    Oliveira, Cristiane
    Lourenco, Gustavo J.
    Silva, Priscilla M. R.
    Cardoso-Filho, Cassio
    Favarelli, Maira H. C.
    Goncales, Neiva S. L.
    Gurgel, Maria S. C.
    Lima, Carmen S. P.
    TUMOR BIOLOGY, 2011, 32 (02) : 295 - 300
  • [38] Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine
    Joerger, M.
    Burgers, J. A.
    Baas, P.
    Doodeman, V. D.
    Smits, P. H. M.
    Jansen, R. S.
    Vainchtein, L. D.
    Rosing, H.
    Huitema, A. D. R.
    Beijnen, J. H.
    Schellens, J. H. M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (01) : 25 - 33
  • [39] Polymorphisms in Radio-Responsive Genes and Its Association with Acute Toxicity among Head and Neck Cancer Patients
    Venkatesh, Goutham Hassan
    Manjunath, Vadhiraja Bejadi
    Mumbrekar, Kamalesh Dattaram
    Negi, Hitendra
    Fernandes, Donald Jerard
    Sharan, Krishna
    Banerjee, Sourjya
    Sadashiva, Satish Rao Bola
    PLOS ONE, 2014, 9 (03):
  • [40] Analysis of VEGF gene polymorphisms and serum VEGF protein levels contribution in polycystic ovary syndrome of patients
    Bao, Lei
    Syed, Rabbani
    Aloahd, Mustafa Sawsan
    MOLECULAR BIOLOGY REPORTS, 2019, 46 (06) : 5821 - 5829
12345